SCHEMBL4630593

SCHEMBL4630593

O=C(O)CCN1CCN(c2cccc3sccc23)CC1

nearest known ligand 0.60

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 16/20 0.60
DRD2 P14416 16/20 0.60
HTR2A P28223 16/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5507046 0.87 DRD2 (0.56) HTR1ADRD2HTR2A
SCHEMBL10228320 0.84 DRD2 (0.61) HTR1ADRD2HTR2A
SCHEMBL29433199 0.84 DRD2 (0.75) HTR1ADRD2HTR2A
SCHEMBL294174 0.83 DRD2 (0.55) HTR1ADRD2HTR2A
SCHEMBL4574005 0.83 DRD2 (0.64) HTR1ADRD2HTR2A
Oxalic Acid SCHEMBL31256010 0.82 HTR1A (0.53) HTR1ADRD2HTR2A
SCHEMBL293666 0.82 DRD2 (0.65) HTR1ADRD2HTR2A
SCHEMBL22302867 0.81 DRD2 (0.63) HTR1ADRD2HTR2A
SCHEMBL12559512 0.81 DRD2 (0.57) HTR1ADRD2HTR2A
SCHEMBL293734 0.81 DRD2 (0.67) HTR1ADRD2HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1919907-A2 HETEROCYCLIC COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2008-05-14 EP disclosed
EP-1869025-A1 PIPERAZINE-SUBSTITUTED BENZOTHIOPHENES FOR TREATMENT OF MENTAL DISORDERS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-12-26 EP disclosed
WO-2007026959-A2 DERIVATIVES OF 4-PIPERAZIN-1-YL-4-BENZ0 [B] THIOPHENE SUITABLE FOR THE TREATMENT OF CNS DISORDERS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-03-08 WO disclosed
WO-2006112464-A1 PIPERAZINE-SUBSTITUTED BENZOTHIOPHENES FOR TREATMENT OF MENTAL DISORDERS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-10-26 WO disclosed